Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M5,829Revenue (TTM) $M1,067Net Margin (%)12.5Altman Z-Score5.0
Enterprise Value $M5,712EPS (TTM) $0.3Operating Margin %-1.4Piotroski F-Score5
P/E(ttm)40.7Beneish M-Score5.0Pre-tax Margin (%)1.7Higher ROA y-yY
Price/Book2.910-y EBITDA Growth Rate %11.0Quick Ratio1.7Cash flow > EarningsN
Price/Sales5.35-y EBITDA Growth Rate %49.2Current Ratio1.8Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)5.2Higher Current Ratio y-yY
Dividend Yield %--PEG0.9ROE % (ttm)7.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M550ROIC % (ttm)-1.3Gross Margin Increase y-yN

Gurus Latest Trades with OPK

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
OPKJoel Greenblatt 2016-06-30 Add0.03%$8.82 - $11.29
($10.16)
$ 10.594%Add 786.33%267,485
OPKKen Fisher 2016-06-30 Reduce$8.82 - $11.29
($10.16)
$ 10.594%Reduce -0.11%37,826
OPKMario Gabelli 2016-06-30 Reduce$8.82 - $11.29
($10.16)
$ 10.594%Reduce -3.70%97,050
OPKGeorge Soros 2016-03-31 Sold Out -0.01%$7.66 - $11.6
($9.12)
$ 10.5916%Sold Out0
OPKJoel Greenblatt 2016-03-31 Reduce-0.01%$7.66 - $11.6
($9.12)
$ 10.5916%Reduce -74.93%30,179
OPKKen Fisher 2016-03-31 Add$7.66 - $11.6
($9.12)
$ 10.5916%Add 0.11%37,867
OPKMario Gabelli 2016-03-31 Reduce$7.66 - $11.6
($9.12)
$ 10.5916%Reduce -30.39%100,775
OPKGeorge Soros 2015-12-31 Buy 0.01%$8.51 - $11.28
($10.07)
$ 10.595%New holding55,500
OPKJoel Greenblatt 2015-12-31 Buy 0.01%$8.51 - $11.28
($10.07)
$ 10.595%New holding120,369
OPKMario Gabelli 2015-12-31 Reduce$8.51 - $11.28
($10.07)
$ 10.595%Reduce -14.79%144,775
OPKKen Fisher 2015-12-31 Add$8.51 - $11.28
($10.05)
$ 10.595%Add 6.55%37,826
OPKGeorge Soros 2015-09-30 Sold Out -0.04%$8.41 - $17.21
($13.29)
$ 10.59-20%Sold Out0
OPKJoel Greenblatt 2015-09-30 Sold Out -0.01%$8.41 - $17.21
($13.29)
$ 10.59-20%Sold Out0
OPKMario Gabelli 2015-09-30 Add0.01%$8.41 - $17.21
($13.29)
$ 10.59-20%Add 1599.00%169,900
OPKKen Fisher 2015-09-30 Add$8.41 - $17.21
($13.29)
$ 10.59-20%Add 21.58%35,500
OPKJoel Greenblatt 2015-06-30 Buy 0.01%$13.76 - $19.12
($15.53)
$ 10.59-32%New holding42,947
OPKMario Gabelli 2015-06-30 Reduce$13.76 - $19.12
($15.53)
$ 10.59-32%Reduce -9.09%10,000
OPKKen Fisher 2015-03-31 Buy $9.91 - $15.03
($13.01)
$ 10.59-19%New holding29,200
OPKMario Gabelli 2014-09-30 Reduce$8.19 - $9.46
($8.79)
$ 10.5920%Reduce -26.67%11,000
OPKGeorge Soros 2014-06-30 Reduce-0.12%$8.01 - $9.71
($8.73)
$ 10.5921%Reduce -84.24%235,600
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

OPK is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


OPK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2016-09-29Buy3,600$10.67-0.75view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2016-09-28Buy5,400$11.01-3.81view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2016-09-27Buy1,800$11.16-5.11view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2016-09-26Buy1,800$11.04-4.08view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2016-09-23Buy1,800$10.95-3.29view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2016-09-22Buy1,800$10.63-0.38view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2016-09-21Buy1,800$10.461.24view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2016-09-20Buy1,800$10.362.22view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2016-09-19Buy1,800$10.184.03view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2016-09-13Buy10,000$9.956.43view

Press Releases about OPK :

Quarterly/Annual Reports about OPK:

News about OPK:

Articles On GuruFocus.com
Weekly CEO Buys Highlights Sep 26 2016 
Weekly CEO Buys Sep 19 2016 
Weekly CEO Buys Aug 29 2016 
Weekly CEO Buys Highlight Aug 22 2016 
Weekly CEO Buys: Abbott Laboratories, GE, OPKO Health Jul 31 2016 
Weekly CEO Buys: Akamai, Restoration Hardware Jul 23 2016 
Weekly CEO Buys: Ryman Hospitality, OPKO Health, Actuant Corp. Jul 17 2016 
Getting to Know VBI Vaccines Jul 13 2016 
Weekly CEO Buys Highlight Jul 10 2016 
Insider Buys of More Than $100,000: Opko Health Jun 16 2016 

More From Other Websites
Kite, Anavex, G.W. Pharma Help Revive Biotech Sector Chemistry Sep 30 2016
Insiders Cannot Get Enough Of Endurance International And Opko Health Sep 28 2016
OPKO Health Appoints Dr. Benjamin Solomon as Managing Director of GeneDx Sep 27 2016
OPKO Health Appoints Dr. Benjamin Solomon as Managing Director of GeneDx Sep 27 2016
OPKO Health to Present at the Ladenburg Thalmann 2016 Healthcare Conference Sep 19 2016
The Synergy From OPKO’s Acquisition of Transition Therapeutics (OPK) Sep 14 2016
ETF’s with exposure to OPKO Health, Inc. : September 13, 2016 Sep 13 2016
OPKO Health Appoints Jane Pine Wood as Chief Legal and Compliance Officer of BioReference... Sep 13 2016
OPKO Health Appoints Jane Pine Wood as Chief Legal and Compliance Officer of BioReference... Sep 13 2016
OPKO Health, Inc. – Value Analysis (NASDAQ:OPK) : September 12, 2016 Sep 12 2016
OPKO Health, Inc. breached its 50 day moving average in a Bullish Manner : OPK-US : September 9,... Sep 09 2016
OPKO to Present Long-acting Human Growth Hormone (hGH-CTP) Phase 2 Pediatric Growth Hormone... Sep 06 2016
Cocrystal Pharma Receives Investment Through Private Placement Sep 02 2016
OPKO Health to Participate in Upcoming September Conferences Sep 01 2016
OPKO HEALTH, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements... Aug 31 2016
OPKO Health Completes Acquisition of Transition Therapeutics Aug 31 2016
OPKO Health Completes Acquisition of Transition Therapeutics Aug 31 2016
Transition Therapeutics Shareholders Approve Acquisition by OPKO Health Aug 26 2016
Transition Therapeutics Shareholders Approve Acquisition by OPKO Health Aug 26 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)